These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31960153)

  • 1. The Emerging Role of Local Therapy in Metastatic Prostate Cancer.
    Sundahl N; Tree A; Parker C
    Curr Oncol Rep; 2020 Jan; 22(1):2. PubMed ID: 31960153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer.
    Abdel-Aty H; James ND
    Curr Opin Urol; 2022 May; 32(3):277-282. PubMed ID: 35249966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches.
    Damodaran S; Lang JM; Jarrard DF
    J Urol; 2019 May; 201(5):876-885. PubMed ID: 30747897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for metastatic castrate-sensitive prostate cancer.
    Miller RE; Sweeney CJ
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):139-44. PubMed ID: 26976365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
    Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
    Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Prior Local Treatment on the Outcomes of Metastatic Hormone-Sensitive Prostate Cancer: Secondary Analysis of a Randomized Controlled Trial.
    Abdel-Rahman O; Cheung WY
    Clin Genitourin Cancer; 2018 Dec; 16(6):466-472. PubMed ID: 30098982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
    Slaoui A; Albisinni S; Aoun F; Assenmacher G; Al Hajj Obeid W; Diamand R; Regragui S; Touzani A; Bakar A; Mesfioui A; Karmouni T; Ameur A; Elkhader K; Koutani A; Ibnattya A; Roumeguere T; Peltier A
    World J Urol; 2019 Nov; 37(11):2343-2353. PubMed ID: 30706122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES.
    Armstrong AJ; Iguchi T; Azad AA; Villers A; Alekseev B; Petrylak DP; Szmulewitz RZ; Alcaraz A; Shore ND; Holzbeierlein J; Gomez-Veiga F; Rosbrook B; Zohren F; Haas GP; Gourgiotti G; El-Chaar N; Stenzl A
    Eur Urol; 2023 Aug; 84(2):229-241. PubMed ID: 37179240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
    James ND; Spears MR; Clarke NW; Dearnaley DP; De Bono JS; Gale J; Hetherington J; Hoskin PJ; Jones RJ; Laing R; Lester JF; McLaren D; Parker CC; Parmar MKB; Ritchie AWS; Russell JM; Strebel RT; Thalmann GN; Mason MD; Sydes MR
    Eur Urol; 2015 Jun; 67(6):1028-1038. PubMed ID: 25301760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting Intermittent Therapy in Metastatic Prostate Cancer: Can Less Be More in the "New World Order"?
    Shevach J; Sydes MR; Hussain M
    Eur Urol Focus; 2019 Mar; 5(2):125-133. PubMed ID: 30803926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Ali A; Hoyle A; Haran ÁM; Brawley CD; Cook A; Amos C; Calvert J; Douis H; Mason MD; Dearnaley D; Attard G; Gillessen S; Parmar MKB; Parker CC; Sydes MR; James ND; Clarke NW
    JAMA Oncol; 2021 Apr; 7(4):555-563. PubMed ID: 33599706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role for local therapy in oligometastatic prostate cancer.
    Khondakar NR; Owens-Walton J; Daneshvar M; Williams C; O'Connor L; Yerram NK; Pinto PA
    Clin Adv Hematol Oncol; 2021 Jul; 19(7):460-467. PubMed ID: 34236345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of combining prostate brachytherapy and metastasis-directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study.
    Tsumura H; Ishiyama H; Tabata KI; Sekiguchi A; Kawakami S; Satoh T; Kitano M; Iwamura M
    Prostate; 2019 Apr; 79(5):506-514. PubMed ID: 30585345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.
    Gravis G; Boher JM; Chen YH; Liu G; Fizazi K; Carducci MA; Oudard S; Joly F; Jarrard DM; Soulie M; Eisenberger MJ; Habibian M; Dreicer R; Garcia JA; Hussain MHM; Kohli M; Vogelzang NJ; Picus J; DiPaola R; Sweeney C
    Eur Urol; 2018 Jun; 73(6):847-855. PubMed ID: 29475737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
    Parker CC; James ND; Brawley CD; Clarke NW; Hoyle AP; Ali A; Ritchie AWS; Attard G; Chowdhury S; Cross W; Dearnaley DP; Gillessen S; Gilson C; Jones RJ; Langley RE; Malik ZI; Mason MD; Matheson D; Millman R; Russell JM; Thalmann GN; Amos CL; Alonzi R; Bahl A; Birtle A; Din O; Douis H; Eswar C; Gale J; Gannon MR; Jonnada S; Khaksar S; Lester JF; O'Sullivan JM; Parikh OA; Pedley ID; Pudney DM; Sheehan DJ; Srihari NN; Tran ATH; Parmar MKB; Sydes MR;
    Lancet; 2018 Dec; 392(10162):2353-2366. PubMed ID: 30355464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.
    Burdett S; Boevé LM; Ingleby FC; Fisher DJ; Rydzewska LH; Vale CL; van Andel G; Clarke NW; Hulshof MC; James ND; Parker CC; Parmar MK; Sweeney CJ; Sydes MR; Tombal B; Verhagen PC; Tierney JF;
    Eur Urol; 2019 Jul; 76(1):115-124. PubMed ID: 30826218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Insights into the Management of Oligometastatic Prostate Cancer: A Comprehensive Review.
    Battaglia A; De Meerleer G; Tosco L; Moris L; Van den Broeck T; Devos G; Everaerts W; Joniau S
    Eur Urol Oncol; 2019 Mar; 2(2):174-188. PubMed ID: 31017094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease volume and distribution as drivers of treatment decisions in metastatic prostate cancer: From chemohormonal therapy to stereotactic ablative radiotherapy of oligometastases.
    Saluja R; Cheung P; Zukotynski K; Emmenegger U
    Urol Oncol; 2016 May; 34(5):225-32. PubMed ID: 27008982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for oligometastatic prostate cancer.
    Dorff TB; Sweeney CJ
    Curr Opin Urol; 2017 Nov; 27(6):553-558. PubMed ID: 28817399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.
    Davda R; Hughes S; Jones R; Crabb SJ; Troup J; Payne H
    Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):376-85. PubMed ID: 26874654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.